Pharmacogenetics of Direct Oral Anticoagulants
For more than 50 years, oral vitamin K antagonists were the choice of anticoagulant for the long-term treatment and prevention of arterial and venous thromboembolic events. In recent years, four direct oral anticoagulants (DOACs), dabigatran, rivaroxaban, apixaban and edoxaban have been compared wit...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2021
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/75043 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Pharmacogenetics of Direct Oral Anticoagulants
- Laboratory Monitoring of Direct Oral Anticoagulants
- New Oral Anticoagulants in Atrial Fibrillation
- Anticoagulation
- Telemedicine For Managing Patients on Oral Anticoagulant Therapy
- Direct Oral Anticoagulants and Vitamin K Antagonists: Role in Thrombotic Damage, Safety, and Indications
- Anticoagulation in Thrombophilia